Actions and Consequences of Insulin in the Striatum.
Jyoti C PatelKenneth D CarrMargaret E RicePublished in: Biomolecules (2023)
Insulin crosses the blood-brain barrier to enter the brain from the periphery. In the brain, insulin has well-established actions in the hypothalamus, as well as at the level of mesolimbic dopamine neurons in the midbrain. Notably, insulin also acts in the striatum, which shows abundant expression of insulin receptors (InsRs) throughout. These receptors are found on interneurons and striatal projections neurons, as well as on glial cells and dopamine axons. A striking functional consequence of insulin elevation in the striatum is promoting an increase in stimulated dopamine release. This boosting of dopamine release involves InsRs on cholinergic interneurons, and requires activation of nicotinic acetylcholine receptors on dopamine axons. Opposing this dopamine-enhancing effect, insulin also increases dopamine uptake through the action of insulin at InsRs on dopamine axons. Insulin acts on other striatal cells as well, including striatal projection neurons and astrocytes that also influence dopaminergic transmission and striatal function. Linking these cellular findings to behavior, striatal insulin signaling is required for the development of flavor-nutrient learning, implicating insulin as a reward signal in the brain. In this review, we discuss these and other actions of insulin in the striatum, including how they are influenced by diet and other physiological states.
Keyphrases
- type diabetes
- glycemic control
- prefrontal cortex
- uric acid
- parkinson disease
- functional connectivity
- magnetic resonance imaging
- resting state
- spinal cord
- white matter
- induced apoptosis
- poor prognosis
- magnetic resonance
- computed tomography
- signaling pathway
- neuropathic pain
- cell death
- blood brain barrier
- metabolic syndrome
- cell proliferation
- pi k akt